PMC Stock Overview
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Pro Medicus Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$64.00 |
| 52 Week High | AU$67.00 |
| 52 Week Low | AU$35.20 |
| Beta | 0.47 |
| 1 Month Change | 9.40% |
| 3 Month Change | 3.23% |
| 1 Year Change | 74.86% |
| 3 Year Change | 110.53% |
| 5 Year Change | 389.52% |
| Change since IPO | 1,452.64% |
Recent News & Updates
Recent updates
Shareholder Returns
| PMC | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | 8.5% | -1.8% | 1.8% |
| 1Y | 74.9% | -23.4% | 2.2% |
Return vs Industry: PMC exceeded the German Healthcare Services industry which returned -23.4% over the past year.
Return vs Market: PMC exceeded the German Market which returned 2.2% over the past year.
Price Volatility
| PMC volatility | |
|---|---|
| PMC Average Weekly Movement | 8.7% |
| Healthcare Services Industry Average Movement | 3.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PMC has not had significant price volatility in the past 3 months.
Volatility Over Time: PMC's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | n/a | Sam Hupert | www.promed.com.au |
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products.
Pro Medicus Limited Fundamentals Summary
| PMC fundamental statistics | |
|---|---|
| Market cap | €6.85b |
| Earnings (TTM) | €42.35m |
| Revenue (TTM) | €86.33m |
161.7x
P/E Ratio79.3x
P/S RatioIs PMC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PMC income statement (TTM) | |
|---|---|
| Revenue | AU$142.12m |
| Cost of Revenue | AU$430.00k |
| Gross Profit | AU$141.69m |
| Other Expenses | AU$71.98m |
| Earnings | AU$69.71m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.67 |
| Gross Margin | 99.70% |
| Net Profit Margin | 49.05% |
| Debt/Equity Ratio | 0% |
How did PMC perform over the long term?
See historical performance and comparison